Login to Your Account



IPO Trifecta: CancerVax, Genitope Myogen All Price Public Offerings

By Aaron Lorenzo


Friday, October 31, 2003
A trio of biotech IPOs priced in succession, but the public money appears to be flowing conservatively, some industry observers think. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription